血液透析患者的循环真菌群特征与心血管死亡
在960例血液透析患者的前瞻性队列中,采用内转录间隔区核糖体DNA测序检测基线血清游离真菌群,中位随访2.2年期间205例全因死亡、75例心血管死亡;真菌α多样性和特定真菌属(Wallemia、Cladosporium、Fusarium)与心血管死亡风险升高相关,而与全因死亡无关联。
要点
- 血液透析患者循环真菌α多样性每升高1单位,心血管死亡风险增加(校正HR 1.64,95%CI 1.14–2.39)。
- 血中检出Wallemia、Cladosporium、Fusarium与心血管死亡风险升高相关(校正HR分别为3.79、2.72、2.21)。
- 循环真菌群特征与全因死亡无显著关联,炎症未介导其与心血管死亡的关联。
核心结论
- 血液透析患者的循环真菌群特征与心血管死亡相关,可能作为心血管早发死亡的新型预后生物标志物。
研究设计与样本
- 全国性前瞻性队列研究,纳入960例血液透析患者,采用内转录间隔区核糖体DNA测序检测基线血清游离真菌群,并用Cox模型校正潜在混杂因素。
主要发现
- 患者平均年龄60±13岁,53%为男性,57%患糖尿病,透析龄中位数(四分位间距)为3.1(1.5–5.8)年。
- 严格质控后80%患者检出内转录间隔区rDNA,共鉴定397个真菌分类单元,包括7门、149科、241属。
- 中位随访2.2(1.7–2.4)年期间,205例发生全因死亡,75例发生心血管死亡。
- 真菌α多样性每升高1单位,心血管死亡校正HR为1.64(95%CI 1.14–2.39);Wallemia、Cladosporium、Fusarium的校正HR分别为3.79(95%CI 2.20–6.51)、2.72(95%CI 1.44–5.12)、2.21(95%CI 1.28–3.81)。
- 循环真菌群特征与全因死亡无显著关联,炎症对其与心血管死亡的关联无显著中介效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: The characteristics and roles of circulating fungal DNA signatures (mycobiota) in patients undergoing hemodialysis remain unknown. We found that higher fungal α diversity and presence of specific fungal genera in the blood associated with higher cardiovascular mortality. Circulating mycobiota signatures may serve as novel prognostic biomarkers for premature cardiovascular mortality in patients undergoing hemodialysis. BACKGROUND: Alterations of the circulating microbiota have recently been implicated in the pathogenesis of cardiometabolic disease. However, the evidence is based primarily on bacterial DNA signatures, whereas the characteristics and roles of circulating fungal DNA signatures (mycobiota) remain unknown. METHODS: In a nationwide prospective cohort of 960 patients undergoing hemodialysis, we characterized circulating cell-free mycobiota signatures in baseline serum samples using internal transcribed spacer ribosomal DNA (rDNA) sequencing and examined their associations with all-cause and cardiovascular mortality using Cox models with adjustment for potential confounders. The added predictive ability of circulating mycobiota signatures over known risk factors for premature mortality and the mediation effect of inflammation on their association with mortality were also examined. RESULTS: In this cohort, the mean age of patients was 60±13 years, 53% of patients were male, 57% had diabetes mellitus, and the median (interquartile interval) hemodialysis vintage was 3.1 (1.5–5.8) years. After stringent quality controls, internal transcribed spacer rDNA was detected in 80% of these patients. Taxonomic analysis of the detected rDNA demonstrated a total of 397 fungal taxa, including seven phyla, 149 families, and 241 genera. During a median (interquartile interval) follow-up of 2.2 (1.7–2.4) years, 205 and 75 patients experienced all-cause and cardiovascular death, respectively. Although circulating mycobiota signatures were not associated with all-cause mortality, higher α diversity (adjusted hazard ratio [95% confidence interval], 1.64 [1.14 to 2.39] per one unit higher) and the presence of specific genera (3.79 [2.20 to 6.51], 2.72 [1.44 to 5.12], and 2.21 [1.28 to 3.81] for Wallemia, Cladosporium, and Fusarium, respectively) were significantly associated with higher cardiovascular mortality, without a significant mediation effect of inflammation. Adding these genera to models with known risk factors improved cardiovascular mortality prediction. CONCLUSIONS: Circulating mycobiota signatures were associated with cardiovascular mortality in patients undergoing hemodialysis.
引用
- Sumida K, Mallisetty Y, Chiu CY, et al. Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis. J Am Soc Nephrol. 2025. PMID: 40788689. doi:10.1681/ASN.0000000829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。